 Entasis Therapeutics Holdings Inc NASDAQ: ETTX stock is up sharply after the journal Nature published an article on the potential of its preclinical candidate ETX0462, which could become the first of a new class of antibiotics. ETX0462 is under development for multidrug-resistant Gram-negative and biothreat infections. 